Ganoderma resinaceum
A European relative of reishi, recognizable by the resinous droplets it secretes from the growing edge of its fruiting body. Historically confused with reishi, but with its own, modest body of phytochemical research.
Table of contents
TL;DR
A European relative of reishi, recognizable by the resinous droplets it secretes from the growing edge of its fruiting body. Historically confused with reishi, but with its own, modest body of phytochemical research.
- →Isolated triterpenoid lactones inhibited α-glucosidase activity more strongly than the reference drug acarbose in an in vitro study
- →The purified compound Resinacein S enhanced thermogenesis markers in adipocyte cultures
| Latin name | Ganoderma resinaceum |
|---|---|
| Family | Ganodermataceae |
| Active substances | Lanostane triterpenes (triterpenoid lactones), Resinacein S |
| Form | No standardized supplement exists — only wild-growing fruiting bodies |
| Evidence level | Hypothesis — 2 in vitro studies, no animal or human studies |
| Interactions | Antidiabetic drugs (theoretical hypoglycemia risk), anticoagulant drugs |
| Status | Not commercially available — solely a subject of phytochemical research |
Understand
Overview
Ganoderma resinaceum is a tree-dwelling fungus found mainly at the base of living oak trunks in Europe. It gets its name from the characteristic sticky, resinous droplets that ooze from the growing edge of the fruiting body — a feature that clearly distinguishes it from the reishi mushroom. It was historically confused with reishi in older mycological field guides.
Who could this realistically help, and who probably shouldn't count on it? Even under the most optimistic scenario — confirmation of effects in animal and human studies — we'd be talking about support for post-meal glycemic control, not a replacement for diabetes treatment; currently there's no in vivo data at all. Because of the theoretical risk of additive hypoglycemia, this species in particular shouldn't be combined on one's own with antidiabetic medications without medical supervision.
Where it's found
Ganoderma resinaceum occurs in Europe, mainly at the base of living oak trunks, less often on other hardwood trees. It's recognizable by the sticky, resinous droplets secreted by the growing edge of the fruiting body.
History of use
Ganoderma resinaceum has no documented tradition of medicinal use — in European mycological field guides predating the development of modern taxonomy, it was simply confused with reishi due to a similarly lacquered cap appearance.
Mechanism of action
Several dozen new lanostane triterpenes have been isolated from the fruiting bodies. In one study, selected triterpenoid lactones inhibited α-glucosidase activity more strongly than the reference drug acarbose. In another cell-based study, the purified compound Resinacein S enhanced the expression of thermogenesis markers in adipocytes.
The triterpenoid lactones identified in G. resinaceum inhibit α-glucosidase through the same mechanism as acarbose — slowing the breakdown of complex carbohydrates in the small intestine — though the data come solely from an in vitro enzymatic assay. Separately, Resinacein S affected thermogenesis markers in adipocyte cultures, suggesting a possible distinct mechanism related to the energy expenditure of fat cells.
Isolation of lanostane triterpenes
Several dozen new triterpenes were isolated from the fruiting bodies, including 14 described in one study.
Inhibition of α-glucosidase
Selected triterpenoid lactones inhibited this enzyme more strongly than the reference drug acarbose in an in vitro enzymatic assay.
Resinacein S and adipocyte thermogenesis
The purified compound enhanced the expression of thermogenesis markers in adipocyte cultures.
Evidence: limited — based on 2 studies in this database.
Benefits
Common myths
MythGanoderma resinaceum is simply a variant of reishi with identical uses.
FactIt's a distinct species, and its human evidence base is practically nonexistent compared with G. lucidum.
Practice
Frequently asked questions
Only in vitro data are available, showing that isolated compounds inhibit the enzyme α-glucosidase — there are no studies in humans or animals.
Dosage & timing
Typical dose
No dosing established in human studies
Form
Not available as a standardized commercial supplement
Dosing is informational and reflects the ranges used in the cited studies — it does not replace consulting a doctor or pharmacist.
Best times to take it
- Not applicable
Safety
Side effects & contraindications
Possible side effects
No dedicated safety studies in humans
Contraindications
Insufficient data available; caution analogous to other Ganoderma species
Interactions
Antidiabetic drugs — theoretical risk of additive blood-glucose lowering
Anticoagulant/antiplatelet drugs — theoretical risk
Is it worth taking?
Who it's for
- Isolated triterpenoid lactones inhibited α-glucosidase activity more strongly than the reference drug acarbose in an in vitro study
- The purified compound Resinacein S enhanced thermogenesis markers in adipocyte cultures
Not for
- Insufficient data available; caution analogous to other Ganoderma species
Evidence
Worth knowing
The species name comes from the resinous, sticky droplets secreted by the growing edge of the fruiting body.
Studies
Fourteen triterpenes were isolated, two of which showed stronger α-glucosidase inhibition than acarbose in an in vitro enzymatic assay.
Chen XQ et al., Molecules, 2018
Isolation, Structural Elucidation, and α-Glucosidase Inhibitory Activities of Triterpenoid Lactones from Ganoderma resinaceum
Research hypothesisChen XQ, et al. · Molecules · 2018
Fourteen triterpenes were isolated, two of which showed stronger α-glucosidase inhibition than acarbose in an in vitro enzymatic assay.
View studyTriterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S
Research hypothesisHuang Y, et al. · Food Research International · 2020
A new triterpene, Resinacein S, reduced lipid droplet size and enhanced thermogenesis markers in adipocyte cultures.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
Julia WiśniewskaEditor, Neurohacking & Sleep
Julia writes about nootropics, chronobiology and recovery protocols.
45 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
131 publications on this site
Related entries
4.2Reishi (Ganoderma lucidum)
A functional mushroom with more than 2,000 years of history in Chinese and Japanese medicine, studied for its immune-modulating effects — human clinical evidence, however, remains modest and partly contradictory.
4.1Cordyceps militaris
A laboratory-cultivated functional mushroom — this is the species behind almost every 'cordyceps' supplement sold today. High, stable cordycepin content, but evidence for improved physical performance in humans is still mixed.
4.1Almond Mushroom (Agaricus blazei)
A mushroom from the Brazilian forests studied mainly for immune modulation and blood-sugar support — human evidence is mixed and preliminary, despite the supplement's considerable popularity.
4.1Maitake (Hen of the Woods)
A functional mushroom also known as 'Hen of the Woods,' studied mainly for immune modulation (D-fraction) in oncology and, more preliminarily, for carbohydrate metabolism — evidence in healthy people remains limited.
4.1Cauliflower Mushroom (Sparassis crispa)
A rare, prized forest mushroom with one of the highest documented beta-glucan contents — in Poland it's mainly foraged for the table, while Japanese research into its effects on immunity and blood sugar rests almost entirely on animal models.
4.1King Oyster Mushroom (Pleurotus eryngii)
The largest species in the oyster mushroom genus, prized in the kitchen for its meaty stem — studied in early research, mostly in animal models, for effects on lipid metabolism and blood sugar.
4.5Turkey Tail
The mushroom behind PSK and PSP — the only fungal polysaccharides registered in Japan as drugs supporting chemotherapy. Among the most solid clinical evidence of any functional mushroom, but this is NOT a standalone cancer therapy.
4.4Lion's Mane
A functional mushroom studied for its effect on nerve growth factor (NGF) and cognitive function — human evidence is still preliminary.
Related articles
PoradnikiIntermittent Fasting and Metabolism: Does Fasting Slow It Down?
"Don't go too long without eating, or your body will enter starvation mode and slow your metabolism" — one of the most commonly repeated warnings against intermittent fasting. A controlled 84-hour fasting study shows the opposite: short-term fasting didn't slow resting energy expenditure, it increased it, driven by more than a doubling of norepinephrine. 'Starvation mode' is a real phenomenon, but it applies to longer, more severe caloric restriction — not a fast lasting hours or even a couple of days.
August 23, 2026
PoradnikiLemon Water on an Empty Stomach: Does It Really Speed Up Metabolism?
"Drink a glass of lemon water right after waking up to kickstart your metabolism" is one of the most repeated pieces of advice online, almost always without a source. The truth is more interesting than the myth itself: there's a solid study showing that plain drinking water genuinely, measurably raises metabolic rate — by as much as 24% within an hour of drinking it. The catch is that no human study has ever tested adding lemon to that water for its effect on metabolic rate or weight loss. This isn't a story about a "debunked myth" — it's about a myth nobody has formally tested, and that distinction matters. In this article we separate the two elements: what water actually does, and why we honestly can't say the same about lemon.
August 24, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.